AI assistant
Sending…
LIFECORE BIOMEDICAL, INC. \DE\ — Director's Dealing 2016
Jun 9, 2016
33431_dirs_2016-06-09_86f065d8-df3c-444f-aed2-3bd282d7b22b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LANDEC CORP \CA\ (LNDC)
CIK: 0001005286
Period of Report: 2016-06-07
Reporting Person: HIEBERT LARRY D (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-06-07 | Common Stock | M | 6000 | $11.54 | Acquired | 12301 | Direct |
| 2016-06-07 | Common Stock | M | 1962 | — | Disposed | 10339 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-06-07 | Restricted Stock Unit (RSU) | $ | M | 6000 | Disposed | 2016-06-07 | Common Stock (6000) | Direct |
Footnotes
F1: Restricted Stock Units vested on June 7, 2016.
F2: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis
F3: Mr Hiebert surrendered to the Issuer the right to receive an aggregate of 1,962 shares of Common Stock. Mr. Hiebert did not sell any shares of Common Stock in connection with the foregoing exercise.
More from LIFECORE BIOMEDICAL, INC. \DE\
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Director's Dealing
2026
Mar 3
Board/Management Information
2026
Jan 16
Investor Presentation
2025
Nov 17
Interim / Quarterly Report
2025
Nov 6
Earnings Release
2025
Nov 6
Declaration of Voting Results & Voting Rights Announcements
2025
Oct 31
Major Shareholding Notification
2025
Oct 17
Regulatory Filings
2025
Oct 1